Halozyme prices $72.1M follow-on

Halozyme Therapeutics Inc. (NASDAQ:HALO) raised $72.1 million through the sale of 6.8 million shares at $10.61 in a follow-on underwritten by Barclays. The company proposed the offering late Thursday, when its stock price was $11.11. On Friday, Halozyme was up $0.03 to $11.14. ...